Does genetic test extends the lives of Pancreatic Cancer patients?
Currently, it does not seem so and so one should think and think again about doing them especially for their high cost. Published on March 02, 2020 Background About 25%…
Proton or Photon Radiation?
Published on February 25, 2020 Background Many people with locally advanced cancers are treated with a combination of chemotherapy and either photon or proton radiation. For patients getting chemotherapy and…
Metastatic Renal Cell Cancer, mRCC – Promising Treatment Option with Keytruda + Avastin
Published on February 25, 2020 Background This phase Ib/II study was designed to evaluate the safety and efficacy of a novel immunotherapy and VEGF-directed therapy combination as first line treatment…
Breakthrough Data of DPX-Survivac immunotherapy in Patients with Advanced Recurrent Ovarian Cancer
Published on February 26, 2020 Background In heavily pretreated patients, for whom there remains a tremendous unmet need with limited options beyond single-agent chemotherapy, which generates responses in just 12%…
CAR-T cell therapy brings new hope for Mesothelioma patients but is hard to get
Background While standard protocols such as chemotherapy are still widely used, clinical trials are supporting the discovery of new treatments and some have proven to be very effective. CAR-T cell…
Kidney cancer – Novel drug shows promise in advanced disease
Published on February 15, 2020 Background Scientists report promising activity of the novel an oral first-in-class MK-6482 drug that targets a key driver of clear cell Renal Cell Carcinoma (ccRCC)…
A New Targeted Therapy Pill Extends Lives of Patients with Metastatic Renal Cell Carcinoma, RCC
Background In the phase III trial, more than 300 patients with metastatic RCC were randomly chosen to receive Fotivda (Tivozanib) or Nexavar (Sorafenib) for a median of 19 months. While…
Gastric Cancer – 83.7% respond to Opdivo with Taxol plus Cyramza
The triplet of Opdivo, Cyramza and Paclitaxel showed promising antitumor activity with durable responses in a phase II study of patients with advanced gastric cancer. The impact of PD-L1 expression…
Faslodex + Capivasertib vs Placebo in Metastatic, ER positive Breast Cancer
Published February 5, 2020 Background Capivasertib (AZD5363) is an oral inhibitor of AKT and by that it influences cell division, apoptosis and cell metabolism. The FAKTION study investigated whether the…
Promising efficacy with a new combination of 2 approved drugs – Lenvima plus Keytruda
Published on January 21, 2020 Background In this trial, 137 cancer patients with NO AVAILABLE STANDARD THERAPEUTIC OPTIONS were treated with the combination of Lenvima plus Keytruda. Eligible patients had…
- Go to the previous page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- Go to the next page